118 related articles for article (PubMed ID: 24050241)
1. Using Drosophila as a tool to identify pharmacological therapies for fragile X syndrome.
McBride SM; Holloway SL; Jongens TA
Drug Discov Today Technol; 2013; 10(1):e129-36. PubMed ID: 24050241
[TBL] [Abstract][Full Text] [Related]
2. Using
McBride SM; Holloway SL; Jongens TA
Drug Discov Today Technol; 2012 Sep; 10(1):e129-e136. PubMed ID: 23730322
[TBL] [Abstract][Full Text] [Related]
3. Come FLY with us: toward understanding fragile X syndrome.
Zarnescu DC; Shan G; Warren ST; Jin P
Genes Brain Behav; 2005 Aug; 4(6):385-92. PubMed ID: 16098136
[TBL] [Abstract][Full Text] [Related]
4. Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials.
Braat S; Kooy RF
Neuropharmacology; 2015 Jan; 88():48-54. PubMed ID: 25016041
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome.
McBride SM; Choi CH; Wang Y; Liebelt D; Braunstein E; Ferreiro D; Sehgal A; Siwicki KK; Dockendorff TC; Nguyen HT; McDonald TV; Jongens TA
Neuron; 2005 Mar; 45(5):753-64. PubMed ID: 15748850
[TBL] [Abstract][Full Text] [Related]
6. Fathoming fragile X in fruit flies.
Zhang YQ; Broadie K
Trends Genet; 2005 Jan; 21(1):37-45. PubMed ID: 15680513
[TBL] [Abstract][Full Text] [Related]
7. I Believe I Can Fly!: Use of Drosophila as a Model Organism in Neuropsychopharmacology Research.
Narayanan AS; Rothenfluh A
Neuropsychopharmacology; 2016 May; 41(6):1439-46. PubMed ID: 26576740
[TBL] [Abstract][Full Text] [Related]
8. Brief review of current research in FXS: implications for treatment with psychotropic medication.
Valdovinos MG
Res Dev Disabil; 2007; 28(6):539-45. PubMed ID: 17034990
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-based approaches to treating fragile X.
Dölen G; Carpenter RL; Ocain TD; Bear MF
Pharmacol Ther; 2010 Jul; 127(1):78-93. PubMed ID: 20303363
[TBL] [Abstract][Full Text] [Related]
10. RNA interference: a new mechanism by which FMRP acts in the normal brain? What can Drosophila teach us?
Siomi H; Ishizuka A; Siomi MC
Ment Retard Dev Disabil Res Rev; 2004; 10(1):68-74. PubMed ID: 14994291
[TBL] [Abstract][Full Text] [Related]
11. Modeling age-related diseases in Drosophila: can this fly?
Michno K; van de Hoef D; Wu H; Boulianne GL
Curr Top Dev Biol; 2005; 71():199-223. PubMed ID: 16344106
[TBL] [Abstract][Full Text] [Related]
12. Translational complexity of the fragile x mental retardation protein: insights from the fly.
Broadie K; Pan L
Mol Cell; 2005 Mar; 17(6):757-9. PubMed ID: 15780932
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model.
Heulens I; D'Hulst C; Van Dam D; De Deyn PP; Kooy RF
Behav Brain Res; 2012 Apr; 229(1):244-9. PubMed ID: 22285772
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
[TBL] [Abstract][Full Text] [Related]
15. The neurochemical basis for the treatment of autism spectrum disorders and Fragile X Syndrome.
Hampson DR; Adusei DC; Pacey LK
Biochem Pharmacol; 2011 May; 81(9):1078-86. PubMed ID: 21333634
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of the GABAA receptor in fragile X syndrome.
D'Hulst C; De Geest N; Reeve SP; Van Dam D; De Deyn PP; Hassan BA; Kooy RF
Brain Res; 2006 Nov; 1121(1):238-45. PubMed ID: 17046729
[TBL] [Abstract][Full Text] [Related]
17. Demented flies? Using Drosophila to model human neurodegenerative diseases.
Michno K; van de Hoef D; Wu H; Boulianne GL
Clin Genet; 2005 Jun; 67(6):468-75. PubMed ID: 15857410
[TBL] [Abstract][Full Text] [Related]
18. Behavior in a Drosophila model of fragile X.
McBride SM; Bell AJ; Jongens TA
Results Probl Cell Differ; 2012; 54():83-117. PubMed ID: 22009349
[TBL] [Abstract][Full Text] [Related]
19. Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS).
D'Hulst C; Heulens I; Brouwer JR; Willemsen R; De Geest N; Reeve SP; De Deyn PP; Hassan BA; Kooy RF
Brain Res; 2009 Feb; 1253():176-83. PubMed ID: 19070606
[TBL] [Abstract][Full Text] [Related]
20. Mental retardation genes in drosophila: New approaches to understanding and treating developmental brain disorders.
Restifo LL
Ment Retard Dev Disabil Res Rev; 2005; 11(4):286-94. PubMed ID: 16240406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
